Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
07/17/2012 | CA2318728C Transcriptional regulatory region |
07/17/2012 | CA2266325C A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
07/17/2012 | CA2250723C Multiple epitope fusion protein |
07/12/2012 | WO2012094627A2 Method of production of recombinant glycoproteins with increased circulatory half-life in mammalian cells |
07/12/2012 | WO2012094586A2 Synthetic non-covalently self-assembling bipartite prna chimeras |
07/12/2012 | WO2012094560A2 Promoters, expression cassettes, vectors, kits, and methods for the treatment of achromatopsia and other diseases |
07/12/2012 | WO2012094529A2 Genes implicated in resistance to soybean cyst nematode infection and methods of their use |
07/12/2012 | WO2012094511A2 Compositions and methods for the treatment of orthopedic disease or injury |
07/12/2012 | WO2012094425A2 Biological methods for preparing adipic acid |
07/12/2012 | WO2012094193A2 Methods for enhancing the delivery of gene-transduced cells |
07/12/2012 | WO2012094115A1 Compositions and methods for inhibiting expression of flt3 genes |
07/12/2012 | WO2012094081A2 System and method for identifying and applying peripheral treatment mechanisms for disease |
07/12/2012 | WO2012094004A1 Fusion of peptidoglycan hydrolase enzymes to a protein transduction domain allows eradication of both extracellular and intracellular gram positive pathogens |
07/12/2012 | WO2012093931A1 Antimicrobial fusion compounds and uses thereof |
07/12/2012 | WO2012093833A2 Genome engineering via designed tal effector nucleases |
07/12/2012 | WO2012093821A2 Gene for predicting the prognosis for early-stage breast cancer, and a method for predicting the prognosis for early-stage breast cancer by using the same |
07/12/2012 | WO2012093764A1 Composition containing gene encoding abc transporter proteins for increasing size of plant seed and content of fat stored within seed |
07/12/2012 | WO2012093384A1 Compositions and methods for treatment of ovarian cancer |
07/12/2012 | WO2012093375A1 Metalloporphyrin inducible promoter |
07/12/2012 | WO2012093192A1 Coly-mycin derivatives |
07/12/2012 | WO2012093158A1 Anticancer fusion protein |
07/12/2012 | WO2012093032A1 Fiber selective promoters |
07/12/2012 | WO2012092970A1 Alphabody libraries and methods for producing the same |
07/12/2012 | WO2012092849A1 Polyamide-amine dendrimer or derivative thereof-math1 gene nano particle and use thereof in treatment of hearing loss |
07/12/2012 | WO2012092760A1 Method for obtaining strains highly expressing lipase and use of lipase obtained |
07/12/2012 | WO2012092676A1 Novel cell wall deconstruction enzymes and uses thereof |
07/12/2012 | WO2012092645A1 Novel antisense oligonucleotides |
07/12/2012 | WO2012071216A3 Antibodies for tumor gangliosides |
07/12/2012 | WO2012068065A3 Gpr101 transgenic mice, uses thereof and screening methods |
07/12/2012 | WO2012067933A3 Recombinant escherichia coli having enhanced acetyl-coenzyme a synthetase activity for producing glyerol and glycerol-derived products |
07/12/2012 | WO2012067402A3 Red fluorescent protein fragment having a self-assembly activity, method for preparing same, and method for analyzing protein-protein interactions using same |
07/12/2012 | WO2012058634A3 Epigenomic induced pluripotent stem cell signatures |
07/12/2012 | WO2012057591A9 Resistance gene to xanthomonas axonopodis in soybeans |
07/12/2012 | WO2012048339A3 Selective detection of neisseria meningitidis |
07/12/2012 | WO2012047076A9 Latex secretory tissue-specific srpp promoter derived from hevea brasiliensis and use thereof |
07/12/2012 | WO2012031243A3 dsRNA MOLECULES COMPRISING OLIGONUCLEOTIDE ANALOGS HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS |
07/12/2012 | WO2012030786A3 Canine bocavirus sequences and uses thereof |
07/12/2012 | WO2012027609A3 Extracts from pirin+ and pirin- plants and uses thereof |
07/12/2012 | WO2012027282A3 Recombinant lignocellulose degradation enzymes for the production of soluble sugars from cellulosic biomass |
07/12/2012 | WO2012016215A3 Microbial bioindicators of hydrocarbons in water and in marine sediments and methods for making and using them |
07/12/2012 | WO2012009508A3 Microrna compositions and methods related thereto |
07/12/2012 | WO2011163228A3 Phage-gnrh constructs, their mimics, antigenic compositions, and sequences for immunocontraception of animals and other applications |
07/12/2012 | WO2011143659A3 Nucleic acid isolation methods |
07/12/2012 | WO2011133960A3 Lysosomal storage disease enzyme |
07/12/2012 | WO2009152529A8 Programming and reprogramming of cells |
07/12/2012 | WO2009088256A9 Baculovirus-based vaccines |
07/12/2012 | US20120180166 Methods for producing transgenic plants |
07/12/2012 | US20120180165 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same |
07/12/2012 | US20120180164 Polynucleotides and polypeptides involved in plant fiber development and methods of using same |
07/12/2012 | US20120180163 Woody plants having improved growth characteristics and method for making the same |
07/12/2012 | US20120180162 Generation of high polyhydroxybutrate producing oilseeds |
07/12/2012 | US20120180161 Method of Modifying the Carbohydrate Content of a Plant |
07/12/2012 | US20120180160 Antifungal plant proteins and methods of their use |
07/12/2012 | US20120180159 Drought tolerant plants and related constructs and methods involving genes encoding ferrochelatases |
07/12/2012 | US20120180158 Ubiquitin promoter and methods of use |
07/12/2012 | US20120180157 Isolation and targeted suppression of lignin biosynthetic genes |
07/12/2012 | US20120180156 Genes homologous to the flowering locus t (ft) gene and the use thereof for modulating tuberization |
07/12/2012 | US20120180150 Inositol 1,4,5-triphosphate receptor-binding protein and its non-human transgenic mammalian animals |
07/12/2012 | US20120180144 Animal models of neurological disorders |
07/12/2012 | US20120180143 Transgenic animal model of neurodegenerative disorders |
07/12/2012 | US20120180142 Cloned transmembrane receptor for 24-hydroxylated vitamin d compounds and uses thereof |
07/12/2012 | US20120180141 Transgenic Animal Models of Disease |
07/12/2012 | US20120178917 Rna aptamers and methods for identifying the same |
07/12/2012 | US20120178912 RECEPTOR ACTIVATOR OF NF-kappaB |
07/12/2012 | US20120178901 Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof |
07/12/2012 | US20120178796 Splice variants |
07/12/2012 | US20120178795 Rnai-mediated inhibition of frizzled related protein-1 for treatment of glaucoma |
07/12/2012 | US20120178794 RNAi-Mediated Inhibition of RHO Kinase for Treatment of Ocular Disorders |
07/12/2012 | US20120178702 Stable lipid-comprising drug delivery complexes and methods for their production |
07/12/2012 | US20120178693 Cofactors for Thrombin Activation of Factor VII and Uses Thereof |
07/12/2012 | US20120178691 Factor viii compositions and methods of making and using same |
07/12/2012 | US20120178685 Fgf21 mutants and uses thereof |
07/12/2012 | US20120178668 Proteinaceous compounds and uses therefor |
07/12/2012 | US20120178649 Methods of constructing and screening diverse expression libraries |
07/12/2012 | US20120178647 Engineering of zinc finger arrays by context-dependent assembly |
07/12/2012 | US20120178169 Tal effector-mediated dna modification |
07/12/2012 | US20120178168 Method for regulating protein function in cells using synthetic small molecules |
07/12/2012 | US20120178167 Methods for Transfecting Nucleic Acid Into Live Cells |
07/12/2012 | US20120178166 Simplified basic media for human pluripotent cell culture |
07/12/2012 | US20120178163 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same |
07/12/2012 | US20120178157 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
07/12/2012 | US20120178156 Genetic variant of the annexin a5 gene |
07/12/2012 | US20120178143 Alpha/beta hydrolase-fold enzymes |
07/12/2012 | US20120178142 Ketoreductases and Uses Thereof |
07/12/2012 | US20120178141 Luciferases and methods for making and using the same |
07/12/2012 | US20120178140 Modified Clostridial Toxins with Enhanced Targeting Capabilities For Endogenous Clostridial Toxin Receptor Systems |
07/12/2012 | US20120178135 Enhanced production of lipids containing polyenoic fatty acids by very high density cultures of eukaryotic microbes in fermentors |
07/12/2012 | US20120178132 Endoglucanases |
07/12/2012 | US20120178131 Tal effector-mediated dna modification |
07/12/2012 | US20120178127 Nucleic acid encoding apoptotic anti-ige antibodies |
07/12/2012 | US20120178126 Methods and materials for increasing expression of recombinant polypeptides |
07/12/2012 | US20120178124 Sterol side chain-cleaving enzyme protein and use thereof |
07/12/2012 | US20120178116 Polypeptides for identifying fungicidally active compounds |
07/12/2012 | US20120178115 Mutants of Pyrroloquinoline Quinine-Dependent Soluble Glucose Dehydrogenase |
07/12/2012 | US20120178110 Screening of protein candidates |
07/12/2012 | US20120178107 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
07/12/2012 | US20120178102 Characterization of granulocytic ehrlichia and methods of use |
07/12/2012 | US20120178090 Method for isolating nucleic acids and protein from a single sample |
07/12/2012 | US20120178088 The tumor suppressor killin |
07/12/2012 | US20120178084 Integrated active flux microfluidic devices and methods |